Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
UNAIDS: AIDS response at risk from funding cuts
UNAIDS report warns the US funding collapse could risk millions of new infections and deaths unless countries transform their HIV responses.
Read more
First and only chikungunya vaccine approved in UK
The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the MHRA.
US authorises waiver for life-saving humanitarian assistance
Marco Rubio has authorised an “Emergency Humanitarian Waiver” that ensures continued access to HIV treatment funded by the US.
US funding pause potential threat to global HIV efforts, warns WHO
The World Health Organization has responded to the US government’s freezing of HIV funding as part of a broader pause in foreign aid.
Spotlight: January 2025
Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in women’s health.
GSK and Oxford unite to advance cancer vaccine research
The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.
Physicians feel unequipped to address women's health gaps
According to new findings by the HBA and FemTechnology, there are significant systemic challenges and unmet needs in women’s healthcare
Takeda takes lead role in Crohn’s Disease biomarker study
Takeda is serving as the Industry Lead in the newly launched INTERCEPT project – a multinational collaboration to identify predictive biomarkers for Crohn’s Disease.
The HBA crowns its '2025 Woman of the Year'
The Healthcare Businesswomen’s Association (HBA) has announced its 2025 winners as Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US.
Loading posts...
« Previous
1
…
8
9
10
11
12
…
30
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View